These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3049146)

  • 21. Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation.
    Guyatt GH; King DR; Feeny DH; Stubbing D; Goldstein RS
    J Clin Epidemiol; 1999 Mar; 52(3):187-92. PubMed ID: 10210235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of three disease-specific and two generic health-status measures to evaluate the outcome of pulmonary rehabilitation in COPD.
    Singh SJ; Sodergren SC; Hyland ME; Williams J; Morgan MD
    Respir Med; 2001 Jan; 95(1):71-7. PubMed ID: 11207021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliability, effect size, and responsiveness of health status measures in the design of randomized and cluster-randomized trials.
    Diehr P; Chen L; Patrick D; Feng Z; Yasui Y
    Contemp Clin Trials; 2005 Feb; 26(1):45-58. PubMed ID: 15837452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Quality-of-life assessment in patients with pulmonary diseases].
    Gvozdenović B; Videnović-Ivanov J
    Med Pregl; 2005; 58 Suppl 1():55-61. PubMed ID: 16526269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A measure of quality of life for clinical trials in chronic lung disease.
    Guyatt GH; Berman LB; Townsend M; Pugsley SO; Chambers LW
    Thorax; 1987 Oct; 42(10):773-8. PubMed ID: 3321537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Juvenile Arthritis Quality of Life Questionnaire--development of a new responsive index for juvenile rheumatoid arthritis and juvenile spondyloarthritides.
    Duffy CM; Arsenault L; Duffy KN; Paquin JD; Strawczynski H
    J Rheumatol; 1997 Apr; 24(4):738-46. PubMed ID: 9101511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinimetric properties of 3 instruments measuring postoperative recovery in a gynecologic surgical population.
    Kluivers KB; Hendriks JC; Mol BW; Bongers MY; Vierhout ME; Brölmann HA; de Vet HC
    Surgery; 2008 Jul; 144(1):12-21. PubMed ID: 18571580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical usefulness of n-of-1 randomized controlled trials in patients with nonreversible chronic airflow limitation.
    Patel A; Jaeschke R; Guyatt GH; Keller JL; Newhouse MT
    Am Rev Respir Dis; 1991 Oct; 144(4):962-4. PubMed ID: 1928975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring health-related quality of life.
    Guyatt GH; Feeny DH; Patrick DL
    Ann Intern Med; 1993 Apr; 118(8):622-9. PubMed ID: 8452328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of life instruments in the evaluation of new drugs.
    Jaeschke R; Guyatt GH; Cook D
    Pharmacoeconomics; 1992 Feb; 1(2):84-94. PubMed ID: 10146938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional status instruments: outcome measure in the evaluation of patients with chronic obstructive pulmonary disease.
    Lareau SC; Breslin EH; Meek PM
    Heart Lung; 1996; 25(3):212-24. PubMed ID: 8635922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measures of functional status and quality of life in chronic obstructive pulmonary disease.
    Cullen DL
    Monaldi Arch Chest Dis; 1999 Apr; 54(2):183-5. PubMed ID: 10394837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring overall health: an evaluation of three important approaches.
    Read JL; Quinn RJ; Hoefer MA
    J Chronic Dis; 1987; 40 Suppl 1():7S-26S. PubMed ID: 3597699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of Life--rationale and methods for developing a disease-specific instrument for inflammatory bowel disease.
    Irvine EJ
    Scand J Gastroenterol Suppl; 1993; 199():22-7. PubMed ID: 8171295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Responsiveness and validity in health status measurement: a clarification.
    Guyatt GH; Deyo RA; Charlson M; Levine MN; Mitchell A
    J Clin Epidemiol; 1989; 42(5):403-8. PubMed ID: 2659745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of health status. Ascertaining the minimal clinically important difference.
    Jaeschke R; Singer J; Guyatt GH
    Control Clin Trials; 1989 Dec; 10(4):407-15. PubMed ID: 2691207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the minimal important difference in symptoms: a comparison of two techniques.
    Redelmeier DA; Guyatt GH; Goldstein RS
    J Clin Epidemiol; 1996 Nov; 49(11):1215-9. PubMed ID: 8892486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life in patients with chronic airflow limitation.
    Guyatt GH; Townsend M; Berman LB; Pugsley SO
    Br J Dis Chest; 1987 Jan; 81(1):45-54. PubMed ID: 3663490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barriers to the use of health status measures in clinical investigation, patient care, and policy research.
    Deyo RA; Patrick DL
    Med Care; 1989 Mar; 27(3 Suppl):S254-68. PubMed ID: 2646491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative responsiveness of generic and specific quality-of-life instruments.
    Wiebe S; Guyatt G; Weaver B; Matijevic S; Sidwell C
    J Clin Epidemiol; 2003 Jan; 56(1):52-60. PubMed ID: 12589870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.